Hey guys. 31 year old male here. I have my consult with Defy tomorrow, but wanted to post my results here so I could get your advice on things to ask about while talking to them, since I am admittedly a newbie to all this.
Long story short - my free T is very low (outside of range) while my SHBG is very high (outside of range), but my Estradiol seems normal. Is that a common set of circumstances? Is there anything you recommend I ask them or bring up to them (outside of symptoms) tomorrow? Thanks a lot, I appreciate all of your input!
Diagnostic Test / Results Results Out of Range Flag Units Range Site Stat
CBC With Differential/Platelet [Final]
Notes Fasting - Yes
WBC x10E3/u 3.4-10.8
L
6.1 01 F
RBC x10E6/u 4.14-5.80
L
4.86 01 F
Hemoglobin 14.4 g/dL 13.0-17.7 01 F
Hematocrit 43.2 % 37.5-51.0 01 F
MCV 89 fL 79-97 01 F
MCH 29.6 pg 26.6-33.0 01 F
MCHC 33.3 g/dL 31.5-35.7 01 F
RDW 12.8 % 12.3-15.4 01 F
Platelets x10E3/u 150-379
L
190 01 F
Neutrophils 52 % Not Estab. 01 F
Lymphs 40 % Not Estab. 01 F
Monocytes 6 % Not Estab. 01 F
Eos 2 % Not Estab. 01 F
Basos 0 % Not Estab. 01 F
Immature Cells NP 01 X
Neutrophils (Absolute) x10E3/u 1.4-7.0
L
3.1 01 F
Lymphs (Absolute) x10E3/u 0.7-3.1
L
2.4 01 F
Monocytes(Absolute) x10E3/u 0.1-0.9
L
0.4 01 F
Eos (Absolute) x10E3/u 0.0-0.4
L
0.1 01 F
Baso (Absolute) x10E3/u 0.0-0.2
L
0.0 01 F
Immature Granulocytes 0 % Not Estab. 01 F
Immature Grans (Abs) x10E3/u 0.0-0.1
L
0.0 01 F
NRBC NP 01 X
Hematology Comments: NP 01 X
Comp. Metabolic Panel (14) [Final]
Glucose 89 mg/dL 65-99 01 F
BUN 23 H mg/dL 6-20 01 F
Creatinine 1.07 mg/dL 0.76-1.27 01 F
eGFR If NonAfricn Am mL/min/1 >59
.73
92 01 F
eGFR If Africn Am mL/min/1 >59
.73
106 01 F
BUN/Creatinine Ratio 21 H 9-20 01 F
Sodium 142 mmol/L 134-144 01 F
Potassium 4.6 mmol/L 3.5-5.2 01 F
Chloride 101 mmol/L 96-106 01 F
Carbon Dioxide, Total 24 mmol/L 20-29 01 F
Calcium 9.8 mg/dL 8.7-10.2 01 F
Protein, Total 7.5 g/dL 6.0-8.5 01 F
Albumin 5.0 g/dL 3.5-5.5 01 F
Globulin, Total 2.5 g/dL 1.5-4.5 01 F
A/G Ratio 2.0 1.2-2.2 01 F
Bilirubin, Total 0.7 mg/dL 0.0-1.2 01 F
Comp. Metabolic Panel (14) [Final]
Alkaline Phosphatase 54 IU/L 39-117 01 F
AST (SGOT) 49 H IU/L 0-40 01 F
ALT (SGPT) 35 IU/L 0-44 01 F
Lipid Panel w/ Chol/HDL Ratio [Final]
Cholesterol, Total 165 mg/dL 100-199 01 F
Triglycerides 47 mg/dL 0-149 01 F
HDL Cholesterol 65 mg/dL >39 01 F
Effective October 22, 2018, HDL Cholesterol
reference interval will be changing to:
Male Female
40 - 999999 50 - 999999
Notes
VLDL Cholesterol Cal 9 mg/dL 5-40 01 F
LDL Cholesterol Calc 91 mg/dL 0-99 01 F
Comment: NP 01 X
T. Chol/HDL Ratio 2.5 ratio 0.0-5.0 01 F
T. Chol/HDL Ratio
Men Women
1/2 Avg.Risk 3.4 3.3
Avg.Risk 5.0 4.4
2X Avg.Risk 9.6 7.1
3X Avg.Risk 23.4 11.0
Notes
Testosterone,Free and Total [Final]
Testosterone, Serum 515 ng/dL 264-916 01 F
Adult male reference interval is based on a population of
healthy nonobese males (BMI <30) between 19 and 39 years old.
Travison, et.al. JCEM 2017,102;1161-1173. PMID: 28324103.
Notes
Free Testosterone(Direct) 6.1 L pg/mL 8.7-25.1 01 F
DHEA-Sulfate [Final]
DHEA-Sulfate 273.2 ug/dL 138.5-475.2 01 F
TSH [Final]
TSH 2.370 uIU/mL 0.450-4.500 01 F
Luteinizing Hormone(LH), S [Final]
LH 7.0 mIU/mL 1.7-8.6 01 F
Prostate-Specific Ag, Serum [Final]
Prostate Specific Ag, Serum 0.4 ng/mL 0.0-4.0 01 F
Roche ECLIA methodology.
.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Notes
IGF-1 [Final]
Insulin-Like Growth Factor I 267 H ng/mL 88-246 02 F
Estradiol, Sensitive [Final]
Estradiol, Sensitive 19.5 pg/mL 8.0-35.0 02 F
Estradiol, Sensitive [Final]
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Notes
Sex Horm Binding Glob, Serum [Final]
Sex Horm Binding Glob, Serum 64.9 H nmol/L 16.5-55.9 01 F
Cardiovascular Report [Final]
Interpretation Note 03 F
Notes Supplemental report is available.